Carlyle Credit Income Fund 7.375% Series D Term Preferred Shares due 2028 (CCID)
Live price chart, market sentiment, and community perspectives for Carlyle Credit Income Fund 7.375% Series D Term Preferred Shares due 2028 (NYSE: CCID).
Live price chart, market sentiment, and community perspectives for Carlyle Credit Income Fund 7.375% Series D Term Preferred Shares due 2028 (NYSE: CCID).
From a quantitative credit-scoring model framework, CCID's yield-to-maturity profile depends heavily on whether the issuer calls the shares prior to 2028 or allows them to run to maturity. Given prevailing credit spreads and benchmark rates, monitoring the net asset value discount or premium relative to par value remains the primary alpha generator for tactical yield seekers in this space.
Evaluating regulatory compliance and structural covenants, the 1940 Act asset coverage requirements act as an ironclad guardrail protecting preferred shareholders. If asset values decline, the fund is legally compelled to de-lever by redeeming preferred shares or rebalancing assets. Understanding the speed and enforceability of these mechanics is essential for anyone sizing long-term allocations in CCID.
Analyzing the macroeconomic backdrop governing Carlyle's underlying collateral pools, floating-rate senior secured loans provide a natural buffer against inflation, which indirectly secures the dividend coverage for these preferred shares. Nevertheless, prolonged high interest rates increase default probabilities among weaker portfolio companies, requiring careful scrutiny of manager underwriting discipline and non-accrual trends within the overarching fund.
As a hedge fund portfolio manager running credit arbitrage strategies, I evaluate CCID through the lens of capital structure seniority. The preferred equity sits comfortably above common equity, absorbing substantial junior losses before principal impairment occurs. However, because these shares have a fixed maturity date in 2028, interest rate sensitivity and the manager's ability to refinance or redeem at par become critical drivers of total return as expiration approaches.
From the options desk perspective, retail and institutional positioning in preferred structures like CCID often suffers from mispriced convexity during periods of systemic credit stress. When broader BDC and closed-end fund sectors experience widening spreads, preferred shares can experience sympathetic secondary selling even when fundamental asset coverage remains well above regulatory thresholds, creating tactical entry points for patient capital.
From a risk management standpoint, term preferred shares issued by closed-end funds investing in senior secured loans offer an interesting risk-reward profile. The 7.375% fixed coupon provides attractive income, but the key analytical hurdle remains asset coverage maintenance tests under the Investment Company Act of 1940. If underlying collateral experiences severe default cycles, portfolio NAV compression can trigger mandatory redemption requirements, introducing liquidity and forced-sale dynamics that risk managers must monitor constantly.
Explore plasma cleansing, somatic organ swaps, and BCI.